DDC and Parkinson disease: Despite several decades of active research into novel therapeutic strategies for PD, L-Dopa given in combination with a peripheral dopa-decarboxylase inhibitor, still remains the most powerful drug to alleviate the motor symptoms of Parkinson’s disease [1, 2].